JP Patent

JP7761732B2 — Ｒｅｔキナーゼ阻害剤としての置換ピラゾロ［１，５－ａ］ピリジン化合物

Assigned to アレイ バイオファーマ インコーポレイテッド · Expires 2025-10-28 · 1y expired

What this patent protects

Patent listed against Retevmo.

Drugs covered by this patent

Patent Metadata

Patent number
JP7761732B2
Jurisdiction
JP
Classification
—
Expires
2025-10-28
Drug substance claim
No
Drug product claim
No
Assignee
アレイ バイオファーマ インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.